Event overview and why it matters for DuPont de Nemours DuPont de Nemours (DD) is in focus after its MemCor membrane bioreactor system was selected for the upgrade of Canberra's Lower Molonglo Water Quality Control Centre, one of Australia's largest wastewater treatment facilities. See our latest analysis for DuPont de Nemours. DuPont de Nemours shares trade at US$138.81 after short term share price weakness over the past week. The year to date share price return of 13.21% and 1 year total...

Stable end-market demand and cost actions are supporting Air Products, DuPont, Avient and Innospec as chemical markets recover.

The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.

DuPont's MemCor MBR system will add about 97 million liters per day of treatment capacity in Canberra as wastewater demand rises with population growth.

DuPont analysis highlights five quality stocks, including PC Connection, Everus Construction and Expeditors International, based on key ROE drivers.

Do you have more faith in DuPont analysis than simple ROE? 5 top-ranked stocks -- CNXN, ECG, BLBD, EXPD and VLO -- stand out on profitability, asset efficiency and leverage scores.

A one-page form you signed on your first day at a job quietly controls who inherits your retirement savings, and it can hand everything to the wrong person no matter what your will says.

DuPont de Nemours has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

Strong semiconductor and aerospace demand drive guidance raise for full year.

Federal law hands one document the power to override your divorce decree, your will, and your new marriage, and most people have not looked at that document since the day they were hired.

Celanese (NYSE:CE) executives said the company expects supply-chain conditions in its Acetyl Chain business to moderate during the second half of 2026, while cost actions, targeted growth initiatives and free-cash-flow generation remain central to its strategy. During the company’s second-quarter e

In the second quarter of 2026, DuPont de Nemours, Inc. reported higher sales of US$1,819 million, a sharp rise in net income to US$143 million, stronger earnings per share, completed a US$775 million share repurchase program, raised its full-year 2026 net sales guidance to US$7.16–7.19 billion, and launched an exchange offer for its 4.725% senior unsecured notes due 2028. Together, the earnings beat, higher guidance, and additional share buybacks highlight management’s confidence in DuPont’s...

DuPont raises its 2026 outlook as pricing, productivity and key end markets point to faster second-half growth.

DuPont de Nemours has delivered a 61.7% return over the past five years, yet the valuation checks send a mixed message, with an intrinsic value estimate suggesting the stock trades at a discount while traditional market multiples point to a richer price tag. Recent strong earnings news and updated company expectations add another layer for investors weighing whether the current share price still makes sense. Over the last five years DuPont de Nemours has returned 61.7%, which puts recent...

DuPont de Nemours (DD) has just reported its second quarter and first half 2026 results, raised full year and second half sales guidance, and announced a fixed income exchange offer tied to its 4.725% 2028 notes. See our latest analysis for DuPont de Nemours. DuPont de Nemours shares are trading at US$142.93, with recent momentum modestly positive given the 1-month share price return of 2.16% and year to date share price return of 16.57%. The 1-year total shareholder return of 59.81% points...

DuPont de Nemours (NYSE:DD) raised its full-year 2026 outlook after reporting second-quarter results that exceeded its prior guidance, supported by organic growth, productivity gains and cash-flow generation. Chief Executive Officer Lori Koch said the company delivered 4% organic sales growth, 80 b

Moby summary of DuPont de Nemours, Inc.'s Q2 2026 earnings call

The company reported earnings per share of $1.88 from sales of $1.8 billion. Wall Street was looking for EPS of $1.76 from sales of $1.8 billion.

DuPont de Nemours Inc (DD) delivers robust Q2 2026 results with 4% organic growth and raises full-year outlook, while navigating margin headwinds and geopolitical challenges.

DuPont topped Q2 earnings and sales estimates, boosted by healthcare, industrial water and aerospace demand, then raised its full-year 2026 outlook.

While the top- and bottom-line numbers for DuPont de Nemours (DD) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

DuPont de Nemours Inc. (NYSE:DD) reported stronger-than-expected second-quarter 2026 results and increased its full-year guidance, although the company’s shares slipped 1.

US equity futures were tracking in the green on Tuesday as traders await the latest batch of corpora

DuPont de Nemours reported a higher profit in the second quarter as sales rose across the chemicals and materials company’s segments.

Today Earnings (a.m.): Merck, Pfizer, McDonald's, Caterpillar, Spotify, Apollo, TPG, Marathon Petroleum, Archer-Daniels-Midland, DuPont, Kimberly-Clark Earnings (p.m.): SpaceX, Advanced Micro Devices, ...

A record backlog of plants, led by a new electronics win, is the clearest evidence yet of how Linde keeps topping itself up, and of how slowly that shows up in the stock.

The monthly jobs report comes out Friday. Before that, Elon Musk’s SpaceX will post its first earnings report as a listed company. Also reporting: Walt Disney; tech companies Palantir and Advanced Micro Devices; ride-sharing firms Uber and Lyft; private-equity firms Apollo, Carlyle and TPG; and fast-food chains McDonald's and Wendy’s.

Tronox (TROX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DD is expected to have benefited from its innovation-driven investment, productivity actions and acquisitions amid cost pressures in Q2.

A recovery in end-market demand and self-help measures, including cost cuts and productivity gains, position CC, MEOH, AVNT and DD to beat Q2 earnings estimates.

Dow Inc. (DOW) delivered earnings and revenue surprises of +15.20% and +0.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Collins and Ryerkerk most recently worked at Putnam Investments and Celanese Corporation, respectively.

DOW and DD are pursuing strategic growth strategies as demand and cost pressures persist.

DuPont de Nemours (DD) has drawn fresh attention after launching an end-to-end Direct Lithium Extraction portfolio, offering more than 20 technologies that aim to support scalable lithium production as demand for electric vehicles and energy storage grows. See our latest analysis for DuPont de Nemours. While DuPont de Nemours is pushing into Direct Lithium Extraction and digital water tools, the share price has slipped around 6.8% over the past month and about 5.5% over the past quarter, even...

Earlier in July 2026, DuPont de Nemours launched an end-to-end Direct Lithium Extraction portfolio of more than 20 products spanning sorbents, membranes, and ion exchange resins to support scalable lithium brine processing from initial extraction through final concentration. By combining lithium-selective materials with integrated flowsheet design and lab-to-pilot support, DuPont is positioning its Water Solutions business as a full-service partner for lithium producers seeking customized,...

DD's end-to-end DLE portfolio combines more than 20 technologies to improve lithium recovery across diverse brines.

With a fortress balance sheet and a trove of essential patents, this overlooked display-tech leader has the clear markings of a takeover target.

Ahead of its second-quarter earnings release next month, analysts project DuPont's EPS to fall by double digits.

Do you have more faith in DuPont analysis than in simple ROE calculation? Tap MAMA, EXPD, GWW and ECG.